Replies to post #243053 on Innovation Pharmaceuticals Inc (IPIX)

[Rdunn88]

OK, so what would you do if Aspire requested a RS for financing? Also seems strange Leo is negotiating with lenders if an OM/UP deal was certain... Aspire tied financing to milestones and Leo failed.

[BooDog]

Looking forward to seeing the deal soon. In black and white.


And then GREN!!!

$IPIX

Message in reply to:

Leo has stated on more than one occasion our model was REGN. He also stated that under no circumstance would there be a reverse split. I believe him and for all we know he has a deal ready to be signed that will provide a substantial upfront cash payment so that cash to fund further trials will not be an issue. If a deal like that is inked after 10/1 the shareholders will benefit and the only party I can see being unhappy is Aspire but they have been well compensated and hopefully are still holding a nice chunk of shares that will be far more valuable soon. Go IPIX!!!

[nerby]

A cogent post, full of actual sentences and things, felicitations!

If this happened.....

- May into June, Leo needs a hefty amount of cash, fast, to pay off the Prurisol CRO and fund payroll and legal while he keeps shopping Brilacidin around. Aspire has lost for months on their IPIX investment and will offer only a lopsided agreement, with a date certain that will ensure a good profit. And based on their long due diligence of IPIX, they believe their milestones are fully achievable, as they stated.
- The agreement also ensures some dilution. Leo detests dilution, but he's against a wall. The agreement is finalized in late June.
- Shortly after, let's call it late July, things suddenly get serious between IPIX and a potential partner interested in Brilacidin. How to break up all the potential indications? IPIX will deal only on the enteric gut-related indications, B-OM and B-IBD. And they have quite a good story to show and tell.
- Shortly after, let's call it August 9, a term sheet is signed on enteric Brilacidin. If consummated, IPIX pockets $XX million and can wrap up Prurisol Phase 2, and move Kevetrin and the (big) rest of Brilacidin forward.
- Leo calculates. He can hold out until maybe end October with cash on hand. A deal is not a deal until the fat lady sings.....but he reckons he can get it done. To hell with Aspire and their crappy deal, and the dilution, all those shares for nothing. Does he even delay the application for Brilacidin's BTD, in case the FDA suddenly has a very efficient approval month?
- September, Leo informs Aspire that, due to circumstances outside IPIX's control, they are unlikely to meet any of the agreement milestones by end of the month, so sorry. Aspire begins to liquidate their shares, at most any price they can get.
- Shortly after, let's call it October-ish, IPIX announces their first partnership. The share price surges. Wannabe funding partners fill the hotels close to Beverly.

......if this happens, then Leo and Art have tungsten balls. But it's kinda the only thing that makes sense at this point.